Hemophilia: Understanding Inhibitors
Tuesday, August 01, 2017
Patients with hemophilia (a blood clotting disorder) can develop inhibitors (also called antibodies) when they have an immune response to factor concentrates (the treatment for hemophilia). Treatment of inhibitors is one of the biggest challenges in hemophilia care because patients with inhibitors can face greater risk of bleeding and the technique to get rid of […]
The post Hemophilia: Understanding Inhibitors appeared first on ASH Clinical News.
Understanding Blood Clots
Saturday, July 01, 2017
As many as 900,000 people in the United States develop blood clots annually, and clots are responsible for approximately 100,000 deaths each year. Research has shown that fewer than one in four people has any recognizable signs and symptoms of a blood clot, so understanding the risk for blood clots is an important factor in […]
The post Understanding Blood Clots appeared first on ASH Clinical News.
Navigating Clinical Trials
Thursday, February 02, 2017
The post Navigating Clinical Trials appeared first on ASH Clinical News.
Women and the Risk of Blood Clots
Thursday, December 01, 2016
Nearly 900,000 people are affected by blood clots each year, leading to approximately 100,000 blood clot-related deaths annually. Dangerous blood clots such as deep-vein thrombosis (DVT) often form in the veins of a person’s arm or leg. If a DVT is left untreated, the clot can break loose and travel to the lungs (pulmonary embolism […]
The post Women and the Risk of Blood Clots appeared first on ASH Clinical News.
The Pediatric Patient Living With Sickle Cell Disease
Tuesday, November 01, 2016
Sickle cell disease (SCD) is the most common genetic disorder in the United States, with about 100,000 American who have the disease and another 2 million who carry the trait. As people live with SCD for years, management of this disease and healthy living are important components of care, particularly for the pediatric population. Read […]
The post The Pediatric Patient Living With Sickle Cell Disease appeared first on ASH Clinical News.
Understanding Bone and Blood Marrow Transplants
Saturday, October 01, 2016
Bone marrow is the soft tissue inside the bones that makes blood-forming cells known as blood stem cells. These grow into red blood cells (carry oxygen throughout the body), white blood cells (help fight infections), or platelets (help control bleeding). Healthy marrow and blood cells are needed to live. When a disease such as cancer […]
The post Understanding Bone and Blood Marrow Transplants appeared first on ASH Clinical News.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Tuesday, August 02, 2016
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are cancers that affect the same lymphocytes, a type of white blood cell. CLL and SLL are essentially the same disease. This “Patient Education” tear sheet was produced in collaboration with the Lymphoma Research Foundation (LRF) (www.lymphoma.org). Patient Education: What is CLL?
The post Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma appeared first on ASH Clinical News.
What Is Acute Myeloid Leukemia?
Monday, August 01, 2016
Acute myeloid leukemia (AML) is the most common acute leukemia in the United States, comprising 33 percent of all leukemias. The cancer progresses rapidly if not treated, making timely diagnosis an important goal. Recent diagnostic tests and treatment options such as stem cell transplantation are improving the remission and cure rates for some patients with […]
The post What Is Acute Myeloid Leukemia? appeared first on ASH Clinical News.
Understanding Light Chain Amyloidosis
Friday, July 01, 2016
Amyloidosis is a rare disease that occurs due to a buildup of protein in different vital organs throughout the body. The disease is often misdiagnosed and not well understood, so there is a growing need for education. Light chain amyloidosis is the most common type of amyloidosis. Read below for more information about the diagnosis […]
The post Understanding Light Chain Amyloidosis appeared first on ASH Clinical News.
Understanding Transplant in Lymphoma
Sunday, May 01, 2016
Hematopoietic cell transplantation (HCT), also called stem cell or bone marrow transplantation, is a treatment option for patients with blood cancers such as leukemia, multiple myeloma, or lymphoma. Together with radiation therapy or chemotherapy, HCT is designed to increase the chance of eliminating the blood cancer and restore normal blood cell production. Read on to […]
The post Understanding Transplant in Lymphoma appeared first on ASH Clinical News.